Key Financial Figures - Standalone (₹ in Lakhs)

Quarterly Performance (Q4 FY25):

  • Total Income: ₹221.69
  • Total Expenses: ₹398.93
  • Profit before tax: (₹177.24)
  • Exceptional items: ₹0
  • Profit after tax: (₹175.22)
  • Other Comprehensive Income: ₹0.27
  • Total Comprehensive Income: (₹174.96)
  • Basic EPS: (₹0.52)
  • Diluted EPS: (₹0.52)

Annual Performance (FY25):

  • Total Income: ₹974.86
  • Total Expenses: ₹1,252.49
  • Profit before tax: (₹277.63)
  • Exceptional items: ₹0
  • Profit after tax: (₹275.61)
  • Other Comprehensive Income: ₹0.27
  • Total Comprehensive Income: (₹275.35)
  • Basic EPS: (₹1.24)
  • Diluted EPS: (₹1.24)

Comparative Figures (Q4 FY24):

  • Total Income: ₹552.61
  • Profit after tax: ₹9.91
  • Basic EPS: ₹0.07

Capital Structure:

  • Paid-up equity share capital increased from ₹1,411.36 lakh (FY24) to ₹3,389.93 lakh (FY25)
  • Other equity decreased from ₹1,987.40 lakh (FY24) to ₹1,712.06 lakh (FY25)

Segment-wise Performance (Standalone)

Revenue Breakdown:

  • Manufacturing in Plastic Moulded Components: ₹34.95 (Q4 FY25), ₹778.68 (FY25)
  • Other Income: ₹186.74 (Q4 FY25), ₹196.18 (FY25)
  • Trading in rough emerald: ₹0 (Q4 FY25), discontinued

Segment Results:

  • Manufacturing segment profit before interest and tax: ₹132.23 (Q4 FY25)
  • Unallocable segment loss: (₹302.90) (Q4 FY25)

Consolidated Financial Results

Auditor's Opinion:

Qualified opinion issued by HKG & Associates due to disclaimer opinion on subsidiary Aunik IT Private Limited.

Key Issues with Subsidiary:

  • Trade receivables of ₹2,343.08 lakh without third-party confirmation
  • Trade payables of ₹2,298.01 lakh to Morpheus Care Limited without confirmation
  • Unsecured loans taken from director in violation of Companies Act, 2013
  • Net worth fully eroded with accumulated losses of ₹2.46 crores
  • Going concern uncertainty

Consolidated Financials (₹ in Lakhs):

  • Q4 FY25 Profit after tax: (₹175.92)
  • FY25 Profit after tax: (₹277.59)
  • Basic EPS: (₹1.25) for FY25

Cash Flow Statement (Standalone)

FY25 Performance:

  • Net cash flow from operating activities: (₹1,720.56)
  • Net cash flow from investing activities: (₹76.18)
  • Net cash flow from financing activities: ₹1,760.95
  • Net decrease in cash: (₹35.79)
  • Closing cash balance: ₹38.09

Financing Activities Detail:

  • Net proceeds from issue of equity shares: ₹1,978.56
  • Net proceeds from borrowings: ₹210.62
  • Repayment of borrowing: (₹428.23)

Assets and Liabilities Position

Standalone (as of March 31, 2025):

  • Total Assets: ₹10,726.25 lakh
  • Trade receivables: ₹9,246.38 lakh
  • Inventories: ₹79.28 lakh
  • Total Equity: ₹5,101.99 lakh
  • Total Liabilities: ₹5,624.27 lakh

Consolidated (as of March 31, 2025):

  • Total Assets: ₹13,142.14 lakh
  • Trade receivables: ₹11,589.46 lakh
  • Total Equity: ₹5,025.77 lakh
  • Total Liabilities: ₹8,116.37 lakh

Board Meeting Details:

  • Held on November 21, 2026, from 4:30 PM to 5:30 PM
  • Approved audited results for quarter ended March 31, 2025
  • Unaudited results for quarter ended September 30, 2026 to be disclosed separately

Additional Information

Accounting Policies:

  • Prepared in compliance with Indian Accounting Standards (Ind AS)
  • Figures regrouped for comparability with current period classification
  • Segment reporting as per SEBI Listing Regulations